产品展示更多>>
- SAR405838 1303607-60-4

- SAR405838 1303607-60-4
SAR405838 1303607-60-4
产品描述 描述 MI-77301 (SAR405838))is an orally available MDM2 antagonist with Ki of 0.88 nM. Phase 1.
纯度 98%储存/保存方法 Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution.基本信息 别名 SAR405838可溶性/溶解性 DMSO : 100 mg/mL (177.78 mM; Need ultrasonic)生物活性 靶点 p53,MDM2In vitro(体外研究) MI-77301 (SAR405838) binds to MDM2 with Ki of 0.88 nM. MI-77301 (SAR405838) potently inhibits cell growth in cancer cell lines, including SJSA-1 (IC50, 0.092 μM), RS4;11 (IC50, 0.089 μM), LNCaP (IC50, 0.27 μM), and HCT-116 (IC50, 0.20 μM) cells, and displays high selectivity over cancer cell lines with mutated or deleted p53, including SAOS-2 (IC50, >10 μM), PC-3 (IC50, >10 μM), SW620 (IC50, >10 μM), and HCT-116 (p53-/-) (IC50, >20 μM) cells.In vivo(体内研究) In the SJSA-1 osteosarcoma, acute lymphoblastic leukemia RS4;11, LNCaP prostate cancer, and HCT-116 colon cancer xenograft model, MI-77301 (SAR405838) (p.o.) effectively inhibits tumor growth in a dose-dependent manner (10 mg/kg, 30 mg/kg, 50 mg/kg, 100 mg/kg, and 200 mg/kg,).参考文献 参考文献 研究领域 研究领域 CancerCell cycleCell cycle inhibitorsp53 pathwayCancerOncoproteins/suppressorsTumor suppressorsp53 pathwayApoptosisIntracellularp53 PathwayCell CycleCell Cycle Inhibitorsp53EpigeneticsCell cycleCell Cycle Inhibitorsp53EpigeneticsDNA / RNADNA Damage & RepairDNA Damage Responsep53EpigeneticsTranscriptionCancer susceptibilityTumor SuppressorsNeuroscienceDevelopmentNeuroscienceProcessesDrug DiscoverySmall Molecule DrugLead Compound DiscoverySAR405838 1303607-60-4温馨提示:本产品仅作科研实验使用,不支持临床等研究
